Article written by: OANA PASCU, Physical therapist
.jpg)
Despite advances in psychopharmacology and established
psychotherapeutic interventions, over 40% of patients with
obsessive-compulsive disorder (OCD) do not respond to
conventional treatment approaches. Current transcranial direct
stimulation (TDCS) has recently been proposed as a therapeutic
tool for the relief of treatment-resistant symptoms in patients
with OCD. This review aimed to provide a comprehensive overview
of the current status and future clinical applications of TDCS in
patients with OCD.
A total of 77 patients received TDCS, with a wide variety of
electrode assemblies, targeting mainly the dorsolateral
prefrontal cortex and the orbitofrontal cortex in the motor area.
TDCS appears to be a promising tool to reduce
obsessive-compulsive symptoms, as well as comorbid depression and
anxiety in patients with treatment-resistant OCD.
Obsessive-compulsive disorder (OCD) is a common and
debilitating psychiatric condition that occurs in 2-3% of the
population. Symptoms consist of unwanted intrusive thoughts and
compulsive behaviors, leading to an inability to maintain
social and occupational functioning.
The established treatments consist of a combination of
psychopharmacology (especially the selective serotonin reuptake
inhibitor - SSRI) and psychotherapeutic interventions, such as
cognitive-behavioral therapy - CBT. Despite augmentation
strategies with other psychotropic drugs and advances in
psychopharmacology, it is assumed that nearly 40% of patients
do not show a sufficient response to conventional treatments.
Therefore, the development of new therapeutic approaches is
justified.
Among recently developed therapeutic approaches, non-invasive
brain stimulation (NIBS) techniques, such as transcranial
stimulation, promise to alleviate symptoms and improve
cognitive functioning in various psychiatric conditions.
![i.php?p=poza 9(1).jpg]()
TDCS consists of applying a weak direct current (1-2 mA)
between two electrodes placed on the scalp of a subject.
Neurophysiological studies have reported that depending on
electrode polarity and current intensity, transcranial
stimulation may increase cortical excitability in the vicinity
of the anode, while cathodic tDCS may decrease it. The effects
of TDCS are not limited to the area under the electrodes and
could reach a widespread network of cortical and subcortical
regions that are connected to the target region. The ability of
tDCS to modulate a network is of particular interest, as
abnormal activity and connectivity within the
orbitofrontal-striato-pallidothalamic network is described in
patients with OCD. Indeed, imaging studies in patients with OCD
have shown abnormalities, which can be either hyper- or hypoxic
activities in many regions of the brain along with a widespread
network, including the orbitofrontal cortex (OFC), cingulate
gyrus, thalamus, right and left cerebellum, and parietal
cortex. These abnormalities were revealed at rest, as well as
in symptom-provoking paradigms, according to studies. It has
been hypothesized that the application of TDCS to these
abnormal brain regions would lead to a decrease in
obsessive-compulsive symptoms by modulating the basic abnormal
brain network. The direction of the dorsolateral prefrontal
cortex is based on studies that report beneficial clinical
effects when stimulating this specific region of the brain in
many psychiatric disorders, and on imaging studies, which
report abnormalities of the cortico-striatal-thalamocortical
pathways.
Twelve studies were performed that included clinical effects in
OCD patients, including several case reports, open-label
trials, and a randomized controlled trial including twelve OCD
patients.
In the first case report, no significant effects were observed
after 10 sessions of transcranial stimulation performed for 20
minutes with 2mA on OC symptoms, when the cathode was placed
over the left dorsolateral prefrontal cortex and the extra
cephalic anode (on the neck). Interestingly, the authors
reported a significant decrease in depression and anxiety
symptoms. Other studies have tried different electrode
assemblies and have shown beneficial results on OC symptoms.
Stimulation intensity was set at 2 mA in all studies and the
duration of transcranial stimulation ranged from 20 to 30 min.
The number of sessions varied, most studies had 10 or 20
sessions and one study had 15 sessions. They were delivered
daily or twice a day.
In conclusion, a total of 77 patients with OCD received active
TDCS with different electrode assemblies and most studies
reported a significant effect on the symptomatology studied.
Beneficial effects of TDCS on other symptoms that are often
seen in patients with OCD, such as depression and anxiety, have
also been reported.
Two studies reported that positive effects were observed at
three months. Accordingly, a recent crossover study
investigated the effect of a single session of TDCS on
obsessive-induced anxiety in OCD patients. They reported a
significant decrease in the severity of obsession-induced
anxiety following applied TDCS.
Most of the studies included in the analysis were case reports
and only two studies included more than 10 patients.
The interpretation of the results is thus limited by the small
sample size. Moreover, tDCS parameters were very heterogeneous
during the studies, in terms of electrode mounting, number of
sessions, duration, and the interval between sessions (from 2
hours to one day). These assemblies were based on neuroimaging
studies that showed hypoxicity in the cerebellum in patients
with OCD. However, interesting discoveries have been made that
try to identify the optimal position of the electrode. The
choice to administer 10 to 20 sessions of 20-30 minutes was
extrapolated in most of the data obtained in studies
investigating the clinical effects of TDCS in patients with
depression. However, it is not established that a longer
duration and a longer number of sessions lead to a better and
longer clinical effect.
The clinical characteristics of patients should be considered
when discussing the role of TDCS in the treatment of OCD. OCD
subtypes (obsessions and checks; symmetry and order; cleaning
and washing; hoarding) were also heterogeneous between studies
and could be an important factor to report in future studies.
These differences may also explain the discrepancies observed
between the studies in the term relief of symptoms, from no
effect on OC symptoms to an 80% decrease.
In conclusion, only a few studies have investigated the effects
of transcranial stimulation in OCD, but have shown promising
results, some of them reporting a decrease of> 35%. This
effect is considered clinically significant, considering the
combination with specific medication.
At Centrokinetic you will find Dr. Edis Mustafa , a specialist in medical
recovery, who specializes in tES therapy, treating over 200
patients, and none of them had any side effects. Dr.
Mustafa did his doctorate in tES therapy, being the most
experienced doctor in Romania.
Our specialist, Dr. Edis Mustafa, confidently recommends
this new therapeutic approach, with exceptional personal results
similar to those in various international studies published with
patients treated so far.
Here you can find a detailed list of prices for
transcranial electrical stimulation (tES) services.
Prices
You can find here a detailed list of the prices of
individual services. But any correct recovery process is based
on a mixed plan of therapies and procedures, customized
according to the condition, stage of the condition, patient
profile, and other objective medical factors. As a result, in
order to configure a treatment plan, with the therapies
involved and the prices related to the plan, please make an
appointment here for an initial consultation.